Amarin Corp Plc (AMRN)

[sharinky]

"Totally my speculation - I am a little concerned about insurance's willingness to provide good co-pay. As far as I know, all insurances have a short list of 10 or so drugs which cost them the most and closely monitor their usage. Lipitor used to be on that list. That suggests insurance tightly manages its drug cost. If they're not completely ethical (here comes my speculation), they may play the copay game to direct consumers/patients to cheaper, out-of-pocket DS. I hope this won't happen in the US. "

Currently Amarin provides a coupon which limits out of pocket costs for commercial insurance. I would imagine they will continue to do this until copays are lowered. Take a look at preventive drugs, look them up and how the U.S. Insurance industry handles them because of US laws. They have low copays because the government want patients taking their preventive drugs. Currently most patients get statins for $4 or $0 out of pocket costs. Insurance companies do not direct patients to DS, doctors would need to do that. Once FDA has approved Vascepa, Amarin will finalize access to Vascepa. No other drug will be available in this area, residual risk on top of statins so access will be there and Copays will be low. It will take time but it will happen. In the US, Insurance companies are not going to get away with saying, here take this unsubstantiated fish oil whose label may or may not be correct and whose drug may or may not be oxidized.